Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | TP53 | P04637 | 1/20 | 0.61 |
| ▸ | ADORA3 | P0DMS8 | 4/20 | 0.59 |
| ▸ | ADORA1 | P30542 | 4/20 | 0.59 |
| ▸ | ADORA2A | P29274 | 4/20 | 0.59 |
| ▸ | PDE2A | O00408 | 1/20 | 0.59 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.59 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.59 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.59 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.51 |
| ▸ | HTR2C | P28335 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8904700 | 0.89 | LMNA (0.61) | LMNATP53ADORA3ADORA1ADORA2A | |
| SCHEMBL8904692 | 0.89 | LMNA (0.61) | LMNATP53ADORA3ADORA1ADORA2A | |
| SCHEMBL6560300 | 0.87 | LMNA (0.80) | LMNATP53ADORA3ADORA1ADORA2A | |
| SCHEMBL6560285 | 0.87 | LMNA (0.80) | LMNATP53ADORA3ADORA1ADORA2A | |
| SCHEMBL11311014 | 0.86 | LMNA (0.65) | LMNATP53ADORA3ADORA1ADORA2A | |
| SCHEMBL11311032 | 0.86 | LMNA (0.65) | LMNATP53ADORA3ADORA1ADORA2A | |
| SCHEMBL11311023 | 0.86 | LMNA (0.65) | LMNATP53ADORA3ADORA1ADORA2A | |
| SCHEMBL7198801 | 0.80 | ADORA3 (0.72) | LMNATP53ADORA3ADORA1ADORA2A | |
| SCHEMBL6399918 | 0.80 | ADORA2A (0.76) | LMNATP53ADORA3ADORA1ADORA2A | |
| SCHEMBL3437027 | 0.80 | ADORA3 (0.72) | LMNATP53ADORA3ADORA1ADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060094869-A1 | Selective process for producing an anomer of a 1-phosphorylated saccharide derivative and process for producing a nucleoside | MITSUI CHEMICALS, INC. (JP) | 2006-05-04 | — | — | US | claimed |
| US-20020193314-A1 | Process for selectively producing 1-phosphorylated sugar derivative anomer and process for producing nucleoside | MITSUI CHEMICALS, INC. (JP) | 2002-12-19 | — | — | US | claimed |
| EP-1178051-A2 | PROCESS FOR SELECTIVELY PRODUCING 1-PHOSPHORYLATED SUGAR DERIVATIVE ANOMER AND PROCESS FOR PRODUCING NUCLEOSIDE | Mitsui Chemicals, Inc. (JP) | 2002-02-06 | — | — | EP | claimed |
| EP-1925675-B1 | Process for production of nucleoside compound | MITSUI CHEMICALS INC (JP) | 2010-02-03 | — | — | EP | disclosed |
| EP-1338654-B1 | PROCESS FOR PRODUCING NUCLEOSIDE COMPOUND | MITSUI CHEMICALS INC (JP) | 2008-10-15 | — | — | EP | disclosed |
| EP-1925675-A1 | Process for production of nucleoside compound | Mitsui Chemicals, Inc. (JP) | 2008-05-28 | — | — | EP | disclosed |
| US-20060094869-A1 | Selective process for producing an anomer of a 1-phosphorylated saccharide derivative and process for producing a nucleoside | MITSUI CHEMICALS, INC. (JP) | 2006-05-04 | — | — | US | disclosed |
| US-7038039-B2 | Process for selectively producing 1-phosphorylated sugar derivative anomer and process for producing nucleoside | MITSUI CHEMICALS, INC. (JP) | 2006-05-02 | — | — | US | disclosed |
| EP-1179598-B1 | PROCESS FOR PRODUCING NUCLEOSIDE COMPOUND | MITSUI CHEMICALS INC (JP) | 2005-08-10 | — | — | EP | disclosed |
| US-20040219646-A1 | Process for producing nucleoside compound | MITSUI CHEMICALS, INC. (JP) | 2004-11-04 | — | — | US | disclosed |
| CN-1476484-A | Process for producing nucleoside compound | 三井化学株式会社 | 2004-02-18 | — | — | CN | disclosed |
| EP-1338654-A1 | PROCESS FOR PRODUCING NUCLEOSIDE COMPOUND | Mitsui Chemicals, Inc. (JP) | 2003-08-27 | — | — | EP | disclosed |
| US-20020193314-A1 | Process for selectively producing 1-phosphorylated sugar derivative anomer and process for producing nucleoside | MITSUI CHEMICALS, INC. (JP) | 2002-12-19 | — | — | US | disclosed |
| EP-1179598-A1 | PROCESS FOR PRODUCING NUCLEOSIDE COMPOUND | Mitsui Chemicals, Inc. (JP) | 2002-02-13 | — | — | EP | disclosed |
| EP-1178051-A2 | PROCESS FOR SELECTIVELY PRODUCING 1-PHOSPHORYLATED SUGAR DERIVATIVE ANOMER AND PROCESS FOR PRODUCING NUCLEOSIDE | Mitsui Chemicals, Inc. (JP) | 2002-02-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060094869-A1 | Selective process for producing an anomer of a 1-phosphorylated saccharide derivative and process for producing a nucleoside | PNP, MTAP, GALE | LMNA 3037/4885TP53 3475/4885ADORA3 503/4885 |
| US-20020193314-A1 | Process for selectively producing 1-phosphorylated sugar derivative anomer and process for producing nucleoside | PNP, GALE, MTAP | LMNA 3427/4885TP53 3433/4885ADORA3 544/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.